NAN – Morgans rates the stock as Add

By Broker News | More Articles by Broker News

Morgans expects business at Nanosonics will be on a more normal footing from FY23. Forecasts for FY23 and FY24 are downgraded after an increase in cost assumptions to be more in-line with guidance and a decrease in forecast European growth rates.

The broker also defers the revenue contribution from the new CORIS product to FY24 from FY23. While the target price falls to $4.86 from $5.43, the Add rating is retained after a significant share price fall.

Sector: Health Care Equipment & Services.

 

Target price is $4.86.Current Price is $3.09. Difference: $1.77 – (brackets indicate current price is over target). If NAN meets the Morgans target it will return approximately 36% (excluding dividends, fees and charges – negative figures indicate an expected loss).

 

 

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →